尿F2-异前列腺素浓度作为蛛网膜下腔出血后不良预后因素
前瞻性分析2016年5月至2017年1月间20例接受动脉瘤颈显微手术夹闭的aSAH患者的临床数据与尿样,评估尿F2-异前列腺素(F2-IsoPs)作为脑血管痉挛(CVS)生物标志物的作用。aSAH患者尿F2-IsoPs浓度显著高于健康对照(P < 0.001);aSAH后第3天F2-IsoP水平升高与CVS发生(P = 0.015)及1个月(P = 0.042)和4个月(P = 0.027)时神经功能较差相关。第3天尿F2-IsoPs对CVS的预后价值高(曲线下面积0.864,95%CI 0.691-1.000)。
要点
- aSAH患者尿F2-IsoPs浓度显著高于健康对照(P < 0.001)。
- aSAH后第3天F2-IsoP水平升高与CVS发生相关(P = 0.015)。
- 第3天尿F2-IsoPs对CVS的预后价值高(AUC 0.864,95%CI 0.691-1.000)。
核心结论
- 尿F2-IsoPs可能作为aSAH患者的无创预后生化标志物。
- 尿中F2-IsoP水平可能在CVS的发病机制中具有重要意义。
研究设计与样本
- 前瞻性分析2016年5月至2017年1月间20例接受动脉瘤颈显微手术夹闭的aSAH患者的临床数据与尿样。
主要发现
- aSAH患者尿F2-IsoPs浓度显著高于健康对照(P < 0.001)。
- aSAH后第3天F2-IsoP水平升高与CVS发生相关(P = 0.015)。
- aSAH后第3天F2-IsoP水平升高与1个月时神经功能较差相关(P = 0.042)。
- aSAH后第3天F2-IsoP水平升高与4个月时神经功能较差相关(P = 0.027)。
- 第3天尿F2-IsoPs对CVS的预后价值高(曲线下面积0.864,95%CI 0.691-1.000)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of isoprostanes in cerebral vasospasm (CVS) following aneurysmal subarachnoid hemorrhage (aSAH) is controversial. Recent studies have suggested that the level of isoprostanes in cerebrospinal fluid could play a role in outcomes of patients with aSAH. We measured concentration of urinary F2-isoprostanes (F2-IsoPs), which is simple and noninvasive. METHODS: A prospective analysis was performed of clinical data and urine samples of 20 patients with aSAH who underwent microsurgical clipping of the aneurysmal neck between May 2016 and January 2017. The role of F2-IsoPs as a CVS biomarker was analyzed with regard to clinical conditions of patients. Outcome was assessed at discharge and 1-month and 4-month follow-up using the Glasgow Outcome Scale and modified Rankin Scale. RESULTS: The concentration of urinary F2-IsoPs was significantly greater in patients with aSAH than in healthy control subjects (P < 0.001). Additionally, increased F2-IsoP levels on day 3 after aSAH were associated with development of CVS (P = 0.015) and worse neurologic performance after 1 month (P = 0.042) and 4 months (P = 0.027). The prognostic value of urinary F2-IsoPs on day 3 in terms of CVS was found to be high (area under the curve 0.864, 95% confidence interval 0.691-1.000). CONCLUSIONS: Urinary F2-IsoPs may be used as a noninvasive prognostic biochemical marker in patients with aSAH. F2-IsoP levels in urine may have significant implications in pathogenesis of CVS.
引用
- Wiśniewski K, Bieńkowski M, Tomasik B, et al. Urinary F2-Isoprostane Concentration as a Poor Prognostic Factor After Subarachnoid Hemorrhage. World Neurosurg. 2017. PMID: 28782688. doi:10.1016/j.wneu.2017.07.145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。